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A fragment of the DNA-binding protein of adenovirus type 5 has been obtained by controlled chymotryptic 
digestion of the entire molecule. Partial sequence determination indicates that the fragment consists of 
amino acids 174525. The fragment is biologically active as measured by its ability to substitute for the 
entire molecule in a reconstituted DNA replication system. Crystals have been obtained that show dif- 
fraction to 2 A. 
Adenovirus DNA replication DNA-binding protein Chymotryptic core Crystallization 
1. INTRODUCTION 
The adenovirus DNA-binding protein (DBP) is 
one of the best characterized eucaryotic DNA- 
binding proteins. It is the major product of the ear- 
ly region E2a and is produced in large amounts, up 
to 2 x 10’ molecules per cell, during lytic infection 
[ 11. The protein has an apparent Mr of 72 000 upon 
SDS-polyacrylamide gel electrophoresis and it con- 
tains 529 amino acids of known sequence [2]. DBP 
is a multi-functional protein that is necessary for 
viral DNA replication [3,4] and is involved in 
regulation of viral RNA synthesis [5,6], host range 
specificity [7], transformation [B] and possibly 
virus assembly [9]. The protein binds to single- 
stranded DNA [lo] and interacts with the ends of 
double-stranded DNA [ 111. 
Evidence has been obtained that DBP contains 2 
functional domains which can be separated by 
chymotrypsin treatment [ 12,131. The exact border 
of these domains is unknown. The N-terminal do- 
main, consisting of about one-third of the 
molecule, is highly phosphorylated and does not 
bind to DNA. Mutations in this part of the DBP 
influence mainly host specificity and late gene ex- 
pression [2,14]. The C-terminal domain binds to 
DNA. Mutations located in this part display a 
DNA replication deficient phenotype and in- 
fluence early gene expression [5,15]. 
Here we report the exact composition of a 
chymotryptic fragment from the C-terminal do- 
main that is biologically active and has been 
crystallized. 
2. EXPERIMENTAL 
We have described [161 that, when DBP is set up 
for crystallization, crystals of a fragment can be 
obtained. The fragment appeared to have an A4, of 
about 40000 and it could also be obtained and 
crystallized when chymotrypsin was added. We 
have further examined the digestion of DBP by 
chymotrypsin with the aim of controlling the reac- 
tion to obtain better crystals and to define 
chemically the fragment crystallized. The time 
course of digestion of DBP by chymotrypsin is 
shown in fig.1. The best crystals were obtained 
during digestion of DBP at 6 mg/ml in 10 mM 
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Fig.1. Chymotrypsin digestion of Ad5 DNA binding 
protein. Ad5 DBP was digested for various times with 
chymotrypsin under the conditions described in the text. 
Lane 1, standards. Lanes 2-7, incubation for 1,2,3,4,5,6 
h, respectively. Lane 8, starting material. 
Tris-HCl, pH 8.0, 2 M NaCl with 10 pg/ml 
chymotrypsin (Sigma) for 4 h at 25°C. The reac- 
tion was stopped by the addition of excess ben- 
zamidine (final concentration 5 mM). Crystals 
(shown in fig.2) were grown from a solution of 
0.5% protein, 100 mM phosphate buffer, pH 7.2, 
1.6 M NaCI, 5% ethanol. They grew over a period 
of 2 weeks to a maximum size of 0.7 mm x 0.5 x 
0.4 mm. On ‘stills’ the crystals show diffraction to 
about 2 A. A rotation photograph is given in fig.3. 
Precession photographs show that the crystals are 
isomorphous to those obtained earlier [ 161, i.e. or- 
thorhombic, space group P212r21, with a = 79.1 
A, b = 75.7 A, and c = 67.4 A. We have 
measured a complete set of diffraction data to 2.5 
A resolution by means of rotation photography 
and we are searching for heavy atom derivatives. 
2. I. Amino acid composition of the fragment 
Biochemical analysis of the fragment was per- 
formed on material obtained from dissolved 
crystals as well as from the appropriate band in 
SDS gels, corresponding to M, of 39000 (see fig. 1). 
The band was cut out and soaked in IO-times its 
volume of 70% formic acid overnight at room 
temperature. The extraction was repeated and the 
formic acid was evaporated. The residue was 
dissolved in 70% formic acid and chromato- 
graphed on Biogel PlO [ 171. Amino acid analysis 
was performed on 5 pg of the fragment [18] and 
the amino-terminal sequence was analyzed as 
previously described [19] using 500 pmol of the 
crystalline protein fragment or 750 pmol of the 
protein isolated from SDS gels. Both for the 
crystals and the protein from the gel the amino- 
terminal sequence was: 
SVPIVXAWEKGMEAA (V) 
This result places the N-terminus of the fragment 
at position 174 of the sequence of the entire 
Fig.2. Crystals of the 39 kDa fragment. 
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Fig.3. Rotation photograph taken on an Elliott GX21 at We compared the biological activity of the frag- 
33 kV, 130 mA. Crystal to film distance is 75 mm, ment with that of the intact DBP by analysis in a 
temperature 2°C. The edge of the circle corresponds to reconstituted DNA replication system. Ad5 DNA, 
2.3 A. isolated from virions and complexed with the ter- 
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molecule [2] (see fig.4B). The amino acid composi- 
tion (fig.4A), in conjunction with the kfr of 39000, 
suggests that 4-5 amino acids are missing from the 
carboxy-terminus. To determine the C-terminus, 
250 pmol of the crystalline fragment or the 
chymotryptic fragment from the SDS gel were 
dissolved in 0.1 M pyridine acetate buffer contain- 
ing 0.5% oligo-oxyethylene. 5 pg carboxypeptidase 
A (Sigma, diisopropylphosphate-treated) was add- 
ed and incubated for various times. This procedure 
liberated Asn and Glu. Since carboxypeptidase A
will not hydrolyze arginine, this means that the C- 
terminal amino acid both in the crystal and in the 
protein from the gel is Asn at position 525. This is 
supported by the fact that the amino acid composi- 
tion of 174-525 shows the best match with the 
results obtained by amino acid analysis (fig.4A) 
and the observed A4,. 
2.2. The fragment is active in DNA replication 
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Fig.4.(A) Amino acid composition (mol%) of the 
crystalline DBP fragment and the corresponding 39 kDa 
protein from SDS-polyacrylamide gels. (B) Amino acid 
composition of Ad5 DBP (from [2]). The arrows in- 
dicate the borders of the crystallized fragment. 
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Fig.5. The fragment supports DNA replication in vitro. 
Reaction mixtures (30 ,uI) contained 4.5 mM Hepes-KOH 
(pH 7.5), 5 mM MgC12, 0.5 mM dithiothreitol, 2.0 mM 
ATP, 7.5 mM creatine phosphate, 7.5 pg/ml creatine 
kinase, 20 PM each of dATP, dGTP and dTTP, 2.5 PM 
[c-w-32p]dCTP (16 Ci/mmol), 3 mU pTP-pol, 2 pi nuclear 
extract, 1 pg cytosol RNA [21], 30 ng DNA-TP previous- 
ly digested with +YhoI, and variable amounts of DBP. 
After 60 min at 37°C the mixture was analyzed by 
agarose gel electrophoresis in 1% gels containing 0.1% 
SDS [20]. Lanes l-5 show an autoradiogram and lane 6 
the input DNA, stained with ethidium bromide. Lane 1, 
0.3 pg DBP; lane 2, 1 gg DBP, lane 3, no DBP; lane 4. 
0.3 pg fragment; lane 5, 1 pg fragment. 
minal protein (DNA-TP) was digested with X/r01 
to produce two terminal fragments B and C, of 
6146 and 5644 base-pairs, respectively. The mix- 
ture of fragments was incubated with purified 
DBP or fragment, the complex of preterminal pro- 
tein and DNA polymerase (pTP-pol) and a nuclear 
extract from uninfected cells under conditions of 
DNA replication, in the presence of [Cu-32P]dCTP. 
After 60 min at 37°C the reaction mixture was 
analyzed on an agarose-SDS gel as described [20]. 
The results (fig.5) show that without DBP, no 
replication is observed. Both in the presence of 
DBP and of the fragment, specific labeling of the 
origin containing fragments B and C is observed, 
indicating that the fragment can support DNA 
replication as well as the intact molecule. The ac- 
tivity of the 39 kDa fragment was 82% of that of 
the 72 kDa protein at 30,ug/ml, while at lOpg/ml 
the 39 kDa fragment was 1.3-times more active. 
3. DISCUSSION 
The functions of DBP in DNA replication and 
regulation of late transcription are located in 
physically separated domains and may act in- 
dependently [ 15,221. Several reports have shown 
that DBP can be degraded using chymotrypsin 
[ 12,13,23], trypsin [23] or pronase [23] producing 
relatively stable fragments. For chymotrypsin 
digestion, C-terminal fragments with M, ranging 
from 34 000 to 45 000 have been reported [ 13,241. 
We show here that under high salt digestion condi- 
tions a major chymotryptic fragment of-352 amino 
acids is obtained with a calculated A4, of 39 391. A 
minor degradation product of about 34 kDa is 
found also, while upon longer incubation smaller 
fragments are produced (see fig. l), but only the 39 
kDa fragment forms crystals. The preferred 
chymotryptic site at position 173/174 is located 
within a region (amino acids 167-181) which is 
very hydrophobic and for the most part conserved 
in Ad5, Ad7, and Ad12 [15,25]. The remaining N- 
terminal part of DBP is less conserved than the C- 
terminal part. It has an aberrant amino acid com- 
position, containing the majority of the Pro and 
Glu residues, no Cys, Tyr or Trp, and only one His 
and Phe residue out of the 16 and 19 that are pre- 
sent in the entire molecule. This part may account 
for the aberrant mobility of the DBP upon elec- 
trophoresis in SDS-polyacrylamide gels and could 
be responsible for the highly asymmetric con- 
figuration of the native molecule as concluded 
from hydrodynamic studies [ 10,23,26]. The 
presence of the N-terminal part probably prevents 
crystallization of the intact protein. Interestingly, 
crystallization of a fragment of the molecule has 
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also been observed for T4 gene 32 helix destabiliz- 
ing protein [27,28] and the E. cob single-stranded 
DBP [29,30]. The 174-525 fragment could 
substitute for the intact protein in DNA replica- 
tion. The specific activity which we observed was 
dependent on the concentration but of the same 
magnitude as that of the intact molecule. 
We also attempted to assay the activity of the 
crystalline material but the crystals could only be 
dissolved under denaturing conditions, such as 
high pH. Our results fit with those of others show- 
ing that C-terminal fragments could complement 
DNA-negative HStsl25 mutant extracts [24,3 11. 
Apparently this fragment is functional in 
the absence of the N-terminal domain. Its 
3-dimensional structure is currently under 
investigation. 
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